Douglas Fisher

Douglas Fisher

Corporate Officer/Principal at SERA PROGNOSTICS, INC.

Net worth: 170 263 $ as of 2024-03-30

48 year
Health Technology
Health Services
Finance

Profile

Doug joined InterWest's healthcare team in 2009, focusing on biopharmaceutical, diagnostic and medical device investments, and portfolio company support.
He is a board member of Gynesonics and Indi Molecular and a former board member of Lycera, Obalon Therapeutics (NASDAQ: RSLS, acquired by ReShape Lifesciences) and PMV Pharma (NASDAQ GS: PMVP).
Doug is also actively involved in InterWest's investments in PMV Pharma (NASDAQ GS: PMVP), Potenza Therapeutics, Sera Prognostics (NASDAQ: SERA, where he serves as the Chief Business Officer), and Tizona Therapeutics.
Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments.
He was involved with several investments, including Pearl Therapeutics, Interlace Medical (Acquired by Hologic), and Stromedix (Acquired by Biogen Idec).
Prior to joining New Leaf, Doug was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area, consulting for leading pharmaceutical and biotech companies.
Previously, he worked for Centocor (a J&J operating company) in the Global Biologic Strategic Marketing Group.
Doug received an A.B.
in economics with honors and distinction, and a B.S.
in biology with distinction, from Stanford, where he graduated Phi Beta Kappa.
He has an M.D.
from the University of Pennsylvania School of Medicine and an M.B.A.
from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.29%
2024-02-13 43,300 ( 0.29% ) 132 931 $ 2024-03-30
2023-10-26 5,572 ( 0.39% ) 37 332 $ 2024-03-30

Douglas Fisher active positions

CompaniesPositionStart
SERA PROGNOSTICS, INC. Corporate Officer/Principal 2015-04-28
Founder -
Private Equity Investor 2020-08-20
Weavr Health Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Douglas Fisher

Former positions of Douglas Fisher

CompaniesPositionEnd
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Douglas Fisher's experience

Training of Douglas Fisher

Stanford University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
Perelman School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Fisher's experience

Connections

100 +

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
SERA PROGNOSTICS, INC.

Health Services

PMV PHARMACEUTICALS, INC.

Commercial Services

PRECIPIO, INC.

Health Services

Private companies19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

Electronic Technology

Finance

Finance

Weavr Health

See company connections
  1. Stock Market
  2. Insiders
  3. Douglas Fisher